Agreed with you on the part That is not your speculation. It all depnds on the assets, liquidation, cash, recent private placement (like the 100000 shares for $100000) etc... and how much BMSN will poor into REGB as an initial asset...etc.. The price will be set per the above factors and will settle down. It will shoot up if more good news from the Co to follow....
Poker Star you couldn't of explained it any better. People also need to know FDA approvals are never on time. I get involved in clinical studies all the time with my spinal cord injury. FDA is always throwing a wrench in the mix wanting more data. So if the clinical work can't start on time , it will when all the I's are dotted and T's crossed. Shareholders need to keep that in mind. Best To all! This is a great company with a great management team.